@prefix this: . @prefix rdfs: . @prefix xsd: . @prefix sio: . @prefix ncit: . @prefix lld: . @prefix miriam-gene: . @prefix miriam-pubmed: . @prefix eco: . @prefix wi: . @prefix prov: . @prefix pav: . @prefix prv: . @prefix dcterms: . @prefix np: . @prefix dgn-np: . @prefix dgn-gda: . @prefix dgn-void: . dgn-np:NP485698.RAZm03-rR-0eyZQX48HQ8b97QIbmsMN1M2RqsWieHz6XM130_head { this: np:hasAssertion dgn-np:NP485698.RAZm03-rR-0eyZQX48HQ8b97QIbmsMN1M2RqsWieHz6XM130_assertion; np:hasProvenance dgn-np:NP485698.RAZm03-rR-0eyZQX48HQ8b97QIbmsMN1M2RqsWieHz6XM130_provenance; np:hasPublicationInfo dgn-np:NP485698.RAZm03-rR-0eyZQX48HQ8b97QIbmsMN1M2RqsWieHz6XM130_publicationInfo; a np:Nanopublication . dgn-np:NP485698.RAZm03-rR-0eyZQX48HQ8b97QIbmsMN1M2RqsWieHz6XM130_assertion a np:Assertion . dgn-np:NP485698.RAZm03-rR-0eyZQX48HQ8b97QIbmsMN1M2RqsWieHz6XM130_provenance a np:Provenance . dgn-np:NP485698.RAZm03-rR-0eyZQX48HQ8b97QIbmsMN1M2RqsWieHz6XM130_publicationInfo a np:PublicationInfo . } dgn-np:NP485698.RAZm03-rR-0eyZQX48HQ8b97QIbmsMN1M2RqsWieHz6XM130_assertion { miriam-gene:3490 a ncit:C16612 . lld:C0006142 a ncit:C7057 . dgn-gda:DGNd06e5b10ad1f411b5c1b5222f469efc3 sio:SIO_000628 miriam-gene:3490, lld:C0006142; a sio:SIO_001121 . } dgn-np:NP485698.RAZm03-rR-0eyZQX48HQ8b97QIbmsMN1M2RqsWieHz6XM130_provenance { dgn-np:NP485698.RAZm03-rR-0eyZQX48HQ8b97QIbmsMN1M2RqsWieHz6XM130_assertion dcterms:description "[Methylation frequencies in the tumor samples were detected in 18% of samples for the breast cancer 1 gene BRCA1, in 43% of samples for the tissue inhibitor of metalloproteinase 3 gene TIMP-3, in 38% of samples for the cyclin-dependent kinase inhibitor 4A gene p16INK4a, in 54% of samples for the cadherin 13 gene CDH13, in 50% of samples for the death-associated protein kinase gene DAPK, in 11% of samples for the E-cadherin gene ECAD, in 25% of samples for the insulin-like growth factor binding protein 7 gene IGFBP7, in 18% of samples for the Ras association domain family 1 gene RASSF1, in 68% of samples for the adenomatous polyposis coli gene APC, in 7% of samples for the cyclin-dependent kinase inhibitor gene p15, in 18% of samples for the CD44 cell adhesion molecule gene, in 29% of samples for the human Mut-L homolog gene hMLH, in 32% of samples for the human telomerase reverse transcriptase gene hTERT, in 64% of samples for the calcitonin gene-related polypeptide alpha gene CALCA, and in 54% of samples for the estrogen receptor gene ER; however, methylation was not observed in the majority of corresponding nonmalignant tissues.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en; wi:evidence dgn-void:source_evidence_literature; sio:SIO_000772 miriam-pubmed:18286531; prov:wasDerivedFrom dgn-void:befree-20150227; prov:wasGeneratedBy eco:ECO_0000203 . dgn-void:befree-20150227 pav:importedOn "2015-02-27"^^xsd:date . dgn-void:source_evidence_literature a eco:ECO_0000212; rdfs:comment "Gene-disease associations inferred from text-mining the literature."@en; rdfs:label "DisGeNET evidence - LITERATURE"@en . } dgn-np:NP485698.RAZm03-rR-0eyZQX48HQ8b97QIbmsMN1M2RqsWieHz6XM130_publicationInfo { this: dcterms:created "2015-08-25T14:42:26+02:00"^^xsd:dateTime; dcterms:rights ; dcterms:rightsHolder dgn-void:IBIGroup; dcterms:subject sio:SIO_000983; prv:usedData dgn-void:disgenetv3.0rdf; pav:authoredBy , , , , ; pav:createdBy ; pav:version "v3.0.0.0" . dgn-void:disgenetv3.0rdf pav:version "v3.0.0" . }